Esperion Therapeutics

Esperion Therapeutics

Esperion Therapeutics

Esperion Therapeutics discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases.
Founded
2008
Raised
$245.7M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$189,900,000
Post-IPO equity - 2015
$33,000,000
Venture capital - 2013
Team Size
10+
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Esperion Therapeutics makes some noise.